| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/27/2004 | US20040102411 DNA vaccine against feline immunodeficiency virus |
| 05/27/2004 | US20040102408 Method and medicament for inhibiting the expression of a given gene |
| 05/27/2004 | US20040102387 Neutralizing agent for clostridium bacterial neurotoxins and preparation method thereof |
| 05/27/2004 | US20040102379 Fibroblast growth factor homologous factors (FHFs) and methods of use |
| 05/27/2004 | US20040102376 Use of rgm and its modulators |
| 05/27/2004 | US20040101919 Detecting cell wall anchored surface proteins and developing vaccines to diagnose, prevent and treat enterococcus, streptococcus, staphylococcus and bacillus infections |
| 05/27/2004 | US20040101882 Secreted proteins |
| 05/27/2004 | US20040101821 Antiviral antisense therapy |
| 05/27/2004 | US20040101593 Preventives or remedies for tumor of human papillomaviral disease |
| 05/27/2004 | US20040101579 Isoflavones and saponins in defined ratios, menopause, cancer |
| 05/27/2004 | US20040101538 Synergistic mixture of terbinafine with diclofenac or indomethacin; fungicide |
| 05/27/2004 | US20040101536 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group B streptococcal carbohydrates |
| 05/27/2004 | US20040101535 Administering nucleoside, or prodrug thereof; viricides |
| 05/27/2004 | US20040101534 Adjuvant-free peptide vaccine |
| 05/27/2004 | CA2506573A1 Substituted 9a-n-[n'-(benzenesulfonyl)carbamoyl-y-aminopropyl]and 9a-n-[n'-(b-cyaneothyl)-n'-(benzenesulfonyl)carbamoyl-y-aminopropyl]derivatives of 9-deoxo-9-dihydro-9a-aza-9a-homoerithromycin a and 5-0-desosaminyl-9-deoxo-9-dihydro-9a-aza-homoerithronolide a |
| 05/27/2004 | CA2505932A1 Antimicrobial activity of antibodies producing reactive oxygen species |
| 05/27/2004 | CA2505868A1 Ligands |
| 05/27/2004 | CA2505092A1 Lysine mixture and apparatus and method for administering lysine |
| 05/27/2004 | CA2504197A1 Topical parasiticide formulations and methods of treatment |
| 05/27/2004 | CA2503303A1 Flavivirus fusion inhibitors |
| 05/27/2004 | CA2497268A1 Buccal, polar and non-polar spray or capsule containing drugs for treating pain |
| 05/26/2004 | EP1422294A1 Method of making an HPV18 L1 Expression Vector and HPV18 L1,L2 antibodies |
| 05/26/2004 | EP1422218A1 Antiviral agent |
| 05/26/2004 | EP1421956A1 Process for stepwise attachment of polyethylene glycol (PEG) to a polypeptide |
| 05/26/2004 | EP1421951A2 Conserved motif of hepatitis C virus E2/NS1 region |
| 05/26/2004 | EP1421949A1 Hepatitis b virus proliferation inhibitor |
| 05/26/2004 | EP1421946A1 A pharmaceutical being used for treating hiv infection, the composition and uses thereof |
| 05/26/2004 | EP1421942A1 Use of glycyrrhizin and its derivatives as RANTES inducers |
| 05/26/2004 | EP1421939A1 Sustained release preparation of a macrolide compound like tacrolimus |
| 05/26/2004 | EP1421933A1 Use of stilbene compounds in preparing medicaments for treating or preventing diabetes and diseases associated with retrovirus |
| 05/26/2004 | EP1421377A2 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 05/26/2004 | EP1421222A2 Cell culture system for synthesis of infectious hepatitis c virus |
| 05/26/2004 | EP1421198A2 Cell-based high-throughput screening methods |
| 05/26/2004 | EP1421170A2 Therapeutic delivery compositions and methods of use thereof |
| 05/26/2004 | EP1421115A2 Soluble t cell receptor |
| 05/26/2004 | EP1421108A2 Antimicrobial and anti-inflammatory peptides |
| 05/26/2004 | EP1421098A2 Surface proteins of streptococcus pyogenes |
| 05/26/2004 | EP1421093A1 Crystaline clindamycin free base |
| 05/26/2004 | EP1421089A1 4-THIOXO-4,7-DIHYDRO-THIENO 2,3-b]PYRIDINE-5-CARBOXAMIDES AS ANTIVIRAL AGENTS |
| 05/26/2004 | EP1421088A1 4-thioxo-4,7-dihydro-thieno 2,3-b]pyridine-5-carbothioamides as antiviral agents |
| 05/26/2004 | EP1421083A1 Novel imidazopyridine compounds with therapeutic effect |
| 05/26/2004 | EP1421082A1 New piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity |
| 05/26/2004 | EP1421075A1 Piperidine derivatives useful as ccr5 antagonists |
| 05/26/2004 | EP1421070A1 New piperidinyl derivates as modulators of chemokine receptor activity |
| 05/26/2004 | EP1421060A1 Antiviral protease inhibitors |
| 05/26/2004 | EP1420829A2 Immunomodulatory compositions, formulations, and methods for use thereof |
| 05/26/2004 | EP1420825A2 Immunomodulatory compounds and methods of use thereof |
| 05/26/2004 | EP1420824A2 Compound |
| 05/26/2004 | EP1420823A2 Immunogenic compositions containing antigens, gene vectors and adjuvants-loaded biodegradable microspheres |
| 05/26/2004 | EP1420822A2 Modified vaccinia virus ankara for the vaccination of neonates |
| 05/26/2004 | EP1420821A2 Immunologically significant herpes simplex virus antigens and methods for using same |
| 05/26/2004 | EP1420818A1 Antigenic compositions |
| 05/26/2004 | EP1420817A1 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments |
| 05/26/2004 | EP1420808A1 Treatment of tuberculosis using immunomodulator compounds |
| 05/26/2004 | EP1420804A1 Methods and compositions for control of coccidiosis |
| 05/26/2004 | EP1420799A2 Use of atazanavir in hiv therapy |
| 05/26/2004 | EP1420798A2 Treatment and prevention of heat shock protein-associated diseases and conditions |
| 05/26/2004 | EP1420792A2 Products and drug delivery vehicles |
| 05/26/2004 | EP1420783A1 Stable emulsion composition |
| 05/26/2004 | EP1420778A2 Use of mek inhibitors for treating inflammation and virus induced hemorrhagic shock |
| 05/26/2004 | EP1420760A2 Aerosolized decongestants for the treatment of sinusitis |
| 05/26/2004 | EP1420745A2 Use of r-nsaid compounds for anti-hiv treatment |
| 05/26/2004 | EP1420646A1 Antimicrobial agent |
| 05/26/2004 | EP1420645A1 Multivesicular emulsion topical delivery systems |
| 05/26/2004 | EP1313499A4 Method for treating the central nervous system by administration of igf structural analogs |
| 05/26/2004 | EP1296996B1 Purine derivatives |
| 05/26/2004 | EP1251827B1 Nasally administrable antifungal cyclic peptide compositions |
| 05/26/2004 | EP1206258B1 Compositions containing esters for treating parasitic infestations of organisms |
| 05/26/2004 | EP1196443B1 Erythropoietin conjugates with polyethylenglycol |
| 05/26/2004 | EP1165074B1 Viral treatment |
| 05/26/2004 | EP1137645B1 Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group |
| 05/26/2004 | EP1124815B1 Method for producing luteolin and luteolin derivatives |
| 05/26/2004 | EP1117652B1 Tan-1057 derivatives |
| 05/26/2004 | EP1056465A4 Antimicrobial peptides and derived metapeptides |
| 05/26/2004 | EP1036083B1 Novel 9a-azalides |
| 05/26/2004 | EP1027332B1 Novel lactam metalloprotease inhibitors |
| 05/26/2004 | EP0969851B1 Immunomodulatory complex and use thereof in helicobacter diseases |
| 05/26/2004 | EP0929300B1 Cyanidin compositions and therapeutic and diagnostic uses therefor |
| 05/26/2004 | EP0894129B1 Short external guide sequences |
| 05/26/2004 | EP0874819B1 Imides as pde iii, pde iv and tnf inhibitors |
| 05/26/2004 | CN1500152A Nucleic acid vaccines for prevention of flavivirus infection |
| 05/26/2004 | CN1500097A Human monoclonal antibodies to FC Alpha receptor (CD89) |
| 05/26/2004 | CN1500086A Aminopiperidine derivatives |
| 05/26/2004 | CN1500078A Aryl oxime-piperazines useful as CCR5 antagonists |
| 05/26/2004 | CN1499977A Compsns. and method of tissue superoxygenation |
| 05/26/2004 | CN1499930A Antifungal compsn. with enhanced bioavailability |
| 05/26/2004 | CN1498965A Method for preparing elspar modilfied by carbowax |
| 05/26/2004 | CN1498895A Artificial composite deoxygenation oligonucleotide with CpG single chain being contained, and effect of anti SARS virus |
| 05/26/2004 | CN1498630A Method for preparing broad-spectrum antiviral drug of nano total acid of chickweed as well as usage and chickweed acid A |
| 05/26/2004 | CN1498623A Glycyrrhizic acid and its derivative used as RANTES inducer |
| 05/26/2004 | CN1151251C New human-phosphoguanosine reductase, its coding sequence and application |
| 05/26/2004 | CN1151172C Novel membrane proteine P76 of helicobacter pylori |
| 05/26/2004 | CN1151151C Method for producing f-methoxy-quinoline carboxylic acids |
| 05/26/2004 | CN1151148C Farnesy transferase inhibitors having pyrrole structure and process for preparation thereof |
| 05/26/2004 | CN1151131C Piperidine derivatives useful as CCR5 antagonists |
| 05/26/2004 | CN1150936C Honey cream for treating hepatitis B |
| 05/26/2004 | CN1150931C Shuangjinlian oral liquid for curing cold and influenza, and its preparing method |
| 05/26/2004 | CN1150929C Malian granule for clearing away liver fever |
| 05/26/2004 | CN1150914C Injection for antivirus, promoting immunity, and leaukogenic and its preparing process |
| 05/26/2004 | CN1150894C Prepn. process of oral coated medicine grains |